Exhibit 10.61
TERMINATION AGREEMENT
THIS TERMINATION AGREEMENT ("Termination Agreement") is made and entered into this the 10th day of
December, 1998, by and among IGI, INC., a Delaware corporation, having a principal place of business at
Wheat Road & Lincoln Avenue, Buena, New Jersey 08310, IGEN, INC., a Delaware corporation, having a
principal place of business at 103 Springier Building, 3411 Silverside Road, Wilmington, Delaware (hereinafter
referred to as "Igen"), IMMUNOGENETICS, INC., a Delaware corporation, having a principal place of
business at Wheat Road & Lincoln Avenue, Buena, New Jersey 08310 (hereinafter referred to as
"Immunogenetics") [IGI, Inc. and its Affiliates (including but not limited to Igen and Immunogenetics) are
hereinafter collectively referred to as "IGI"], and GLAXO WELLCOME, INC., a North Carolina corporation,
having a principal place of business at Five Moore Drive, Research Triangle Park, North Carolina 27709
(hereinafter referred to as "GW").
W I T N E S S E T H :
WHEREAS, IGI and GW have previously entered into a certain Amended and Restated Exclusive Supply
Agreement, dated as of January 27, 1997, as amended by Amendment No. 1 to the Amended and Restated
Exclusive Supply Agreement, dated as of April 7, 1998, relating to the manufacture and supply by IGI, and the
purchase by GW, of certain facial health products sold by GW under the WellSkin(R) trademark (such
agreement, as amended, hereinafter referred to as the "Supply Agreement"); and
WHEREAS, IGI and GW now mutually desire to terminate the Supply Agreement, subject to the terms and
conditions set forth below.
NOW, THEREFORE, in consideration of the premises, the mutual covenants contained herein and other
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, IGI and GW hereby agree
as follows:
1. Definitions. Except as otherwise defined herein, all capitalized terms used herein but not defined herein shall
have the meanings ascribed to such terms in the Supply Agre